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Melioidosis, an infectious disease caused by the environmental bacterium Burkholderia pseudomallei,
has remained in the shadows for far too long. Described over 100 years ago by Alfred Whitmore in
Rangoon [1], the disease is so neglected that it is not even on any of the lists of neglected tropical
diseases, despite the fact that it probably kills more people each year than diseases that are much better
known, such as leptospirosis and dengue [2]. We aim to set the record straight.
In the first few years after its discovery, melioidosis was considered a relatively rare infection
confined to areas where colonial medical services had been established, for example by the British
in Burma (now Myanmar) [1], Ceylon (now Sri Lanka) [3] and the Federated Malay States (now
Malaysia) [4], the French in Indochina (now Cambodia, Laos and Vietnam) [5–7], and the Dutch in
the Dutch East Indies (now Indonesia) [8–10]. It was the French in Indochina who proved that the
organism was a saprophyte rather than a zoonosis as had originally been suspected [11,12]. It was
discovered for the first time in northern Australia in 1949 [13], although it appears that this is really
where it actually originated [14]. B. pseudomallei appears to have spread from there to southeast
Asia, and thence to Africa and the Americas [15,16]. The disease gained brief notoriety as a cause
of infection amongst French and American troops serving in Southeast Asia [17–19]. Its unusual
ability to remain latent after acquisition and cause a fatal disease many years later has given rise to
the nickname ‘Vietnam Time Bomb’ [20]. B. pseudomallei has more recently been categorised as a ‘Tier
1 Select Agent’ because of its biothreat potential (https://www.ecfr.gov/cgi-bin/retrieveECFR?gp=
&SID=8a4be60456973b5ec6bef5dfeaffd49a&r=PART&n=42y1.0.1.6.61).
Undoubtedly, it was the work of the Infectious Disease Association of Thailand that led to the
recognition that melioidosis was actually a greatly-underestimated public health problem in some
parts of the world. In 1985, they organised a meeting devoted to melioidosis that highlighted 686 cases
of the disease occurring in Thailand over a relatively short time period [21]. This heralded a new
wave of interest in the disease that has culminated in this current special issue of Tropical Medicine
and Infectious Diseases. Writing in 1991, after spending 4 years observing what an important disease
melioidosis was in northeast Thailand [22], one of us reviewed existing evidence and suggested that
the disease was probably far more common worldwide than was currently appreciated [23]. This was
not a new idea, as Fournier had made similar suggestions some 3 decades earlier [24,25]. The reasons
for its under-recognition are a lack of diagnostic microbiology laboratories serving the rural poor in the
tropics, who are most likely to acquire melioidosis, and a lack of familiarity and awareness amongst
medical and laboratory staff, where such laboratories are available. More recently, the prediction
has been vindicated by growing numbers of reports of the disease in new places, and increasing
recognition within known endemic areas [26,27]. In 2016, the first attempt was made to estimate
the global burden of human melioidosis in terms of cases and deaths, the resulting prediction being
165,000 and 89,000 per year, respectively, a mortality burden similar to that of measles [2].
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Now, two years on from this modelling study [2], the time is right to take stock of what we
have learned since then. In this issue, we have combined articles from countries and regions around
the world that summarise the current status, including what is known locally about the burden of
melioidosis, and the key challenges facing local clinicians, laboratory staff and public health and policy
makers, in relation to this elusive but common and fatal disease. We hope that this will become a key
source of information for those who share our concern and are taking actions against this disease.
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